Nephrotic Syndrome in Adult Patients With COVID-19 Infection or Post COVID-19 Vaccine: A Systematic Review.
coronavirus disease 2019
coronavirus vaccine
covid 19
focal segmental glomerulosclerosis (fsgs)
minimal change
nephrotic syndrome
primary membranous nephropathy
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
accepted:
26
09
2022
entrez:
31
10
2022
pubmed:
1
11
2022
medline:
1
11
2022
Statut:
epublish
Résumé
Nephrotic syndrome is a condition characterized by damage to podocytes that results in significant proteinuria, edema, hyperlipidemia, and hypercoagulability. Infections and malignancies are frequently associated with nephrotic syndrome. The COVID-19 virus has been associated with several atypical presentations of upper respiratory infections and acute kidney injury. Considering that COVID-19 causes systemic inflammatory changes, it seems plausible that it may also lead to nephrotic syndrome. This study aimed to investigate if an association between COVID-19 and the different types of nephrotic syndromes exists. Data were extracted into a spreadsheet. Statistical analysis was performed using Statistical Package for Social Sciences (SPSS, IBM Corp., Armonk, NY, USA). We performed a systematic search of PubMed/Medline and Embase databases using both medical subject headings (MeSH) and regular keywords associated with COVID-19 and nephrotic syndrome, including different types of nephrotic syndromes. The search was performed on 17th December 2021. We included case reports and case series about adult patients who developed findings suggestive of nephrotic syndrome shortly after infection or vaccination. We excluded cases involving children, pregnant women, articles written in languages other than English, and those that were not retrievable. The relevance and quality of identified articles were assessed. We included 32 articles in the study, primarily case reports and case series. In our study, COVID-19 and the COVID-19 vaccine have been associated with the development of nephrotic syndrome, primarily a collapsing form of focal segmental glomerulosclerosis, although other forms have been observed as well. There was little consistency in patient histories, clinical presentations, clinical courses, or treatment regimens, although it appeared that most cases eventually resolved. More cases need to be reported and analyzed before more definitive conclusions can be reached. In conclusion, nephrotic syndrome is a possible complication of both COVID-19 infection and the COVD-19 vaccine and should be considered in patients exhibiting sudden onset edemas or deterioration in kidney function. While the majority of cases respond to standard treatment, clearer guidelines will need to be developed once more data is available.
Identifiants
pubmed: 36312654
doi: 10.7759/cureus.29613
pmc: PMC9595350
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e29613Informations de copyright
Copyright © 2022, Cancarevic et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Kidney Int Rep. 2020 Apr 28;5(6):940-945
pubmed: 32346659
Kidney Int. 2021 Nov;100(5):1140-1141
pubmed: 34419553
Trends Mol Med. 2020 May;26(5):483-495
pubmed: 32359479
Patient Saf Surg. 2021 May 1;15(1):20
pubmed: 33933145
Int J Organ Transplant Med. 2020;11(4):145-162
pubmed: 33335696
Ren Fail. 2020 Nov;42(1):877-880
pubmed: 32862747
BMC Nephrol. 2021 Nov 11;22(1):376
pubmed: 34763669
Kidney Int. 2020 Jul;98(1):228-231
pubmed: 32471639
J Nephrol. 2022 Jan;35(1):351-355
pubmed: 34618335
Kidney Int Rep. 2021 Dec;6(12):2969-2978
pubmed: 34632166
Am J Kidney Dis. 2021 Aug;78(2):312
pubmed: 33992727
BMC Nephrol. 2020 Aug 4;21(1):326
pubmed: 32753052
Kidney Int. 2021 Aug;100(2):461-463
pubmed: 34000278
Transplantation. 2021 Jan 1;105(1):206-211
pubmed: 32852403
Can J Kidney Health Dis. 2021 Nov 15;8:20543581211058271
pubmed: 34804557
Dtsch Arztebl Int. 2021 Oct 1;118(39):662-663
pubmed: 34919048
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620963635
pubmed: 33019829
Environ Pollut. 2020 Dec;267:115621
pubmed: 33254614
Am J Kidney Dis. 2021 Jul;78(1):142-145
pubmed: 33839200
Case Rep Nephrol. 2020 Sep 28;2020:8820713
pubmed: 33005463
Diabetes Metab Syndr. 2021 Nov-Dec;15(6):102268
pubmed: 34562865
Clin Case Rep. 2021 Oct 23;9(10):e05003
pubmed: 34721864
Inflammopharmacology. 2021 Jun;29(3):645-649
pubmed: 33932192
Kidney Int. 2020 Jul;98(1):241
pubmed: 32471641
J Am Soc Nephrol. 2020 Sep;31(9):1959-1968
pubmed: 32680910
Int J Biol Sci. 2021 Apr 10;17(6):1446-1460
pubmed: 33907508
MMWR Morb Mortal Wkly Rep. 2021 Sep 03;70(35):1228-1232
pubmed: 34473684
Nephrol Dial Transplant. 2021 Aug 27;36(9):1565-1569
pubmed: 34245294
Kidney Int. 2021 Oct;100(4):938-939
pubmed: 34332960
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102205
pubmed: 34293552
J Nephrol. 2020 Dec;33(6):1369-1372
pubmed: 32892322
Am J Kidney Dis. 2021 Mar;77(3):465-468
pubmed: 33217501
Transplant Proc. 2020 Nov;52(9):2693-2697
pubmed: 32972761
World J Virol. 2021 Jul 25;10(4):182-208
pubmed: 34367933
Clin Imaging. 2021 Mar;71:34-38
pubmed: 33171364
Kidney Med. 2020 Jun 07;2(4):488-492
pubmed: 32775989
Am J Kidney Dis. 2020 Oct;76(4):590-594
pubmed: 32668317
J Korean Med Sci. 2021 Aug 02;36(30):e218
pubmed: 34342187
PLoS One. 2021 Dec 2;16(12):e0260899
pubmed: 34855909
World J Clin Cases. 2021 Sep 26;9(27):7986-7997
pubmed: 34621855